Physician profile
Mary K Morrell
NPI 1467452318
$1,114.13
in general payments reported to CMS, 2019-2025
19 companies · $399 in 2025
The $399 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.24 · 2020: $118 · 2021: $78.62 · 2022: $119 · 2023: $228 · 2024: $119 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $745.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $191.34 | 2022-2024 | Trivisc Sodium Hyaluronate, Genvisc 850 Sodium Hyaluronate |
| Horizon Therapeutics Plc | $128.49 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $112.63 | 2022-2025 | Euflexxa |
| Orthofix Medical, INC. | $93.00 | 2023-2025 | Physio-Stim |
| Pacira Pharmaceuticals Incorporated | $67.43 | 2023-2025 | Exparel, Zilretta, Iovera |
| Vertex Pharmaceuticals Incorporated | $65.88 | 2024-2025 | |
| Bioventus LLC | $63.61 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Catalyst Orthoscience | $54.56 | 2025 | |
| Orthalign INC | $51.75 | 2025 | Orthalign Plus |
| Smith+Nephew, INC. | $49.91 | 2025 | Pico 14 |
| Stryker Corporation | $43.96 | 2020-2025 | Mako |
| Ethicon US, LLC | $39.26 | 2020-2021 | |
| Depuy Synthes Sales INC. | $32.94 | 2021-2023 | Orthovisc, Monovisc |
| Convatec INC. | $25.47 | 2023 | |
| Heron Therapeutics, INC. | $23.49 | 2025 | Zynrelef |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthogenrx INC. | $21.92 | 2021 | |
| Davol INC. | $19.40 | 2023 | |
| Zimvie INC. | $14.85 | 2023 | |
| Ibsa Pharma INC. | $14.24 | 2024 | Licart, Tirosint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Morrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.